Glioblasztóma: vizsgálatok itt: Kanada
18 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleTamoxifen Versus Etoposide After First Recurrence in GBM Patients
- Where
- Edmonton
- Életkor
- 18 év to 65 év
- People
- 60
- Run by
- AHS Cancer Control Alberta
See details and how to joinNCT04765098 - 2/3. fázisTaking peopleA Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- Where
- Montreal, Sherbrooke, Toronto
- Életkor
- 18 év and over
- People
- 2250 worldwide
- Run by
- Global Coalition for Adaptive Research
See details and how to joinNCT03970447 · EU 2024-511452-40-00 - Korai 1. fázisCsak meghívásosPilot Trial for Treatment of Recurrent Glioblastoma
- Where
- Calgary
- Életkor
- 18 év and over
- People
- 10
- Run by
- AHS Cancer Control Alberta
See details and how to joinNCT05432518 - No phaseTaking peopleUNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-4
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 120
- Run by
- Sunnybrook Health Sciences Centre
See details and how to joinNCT07459101 - 1/2. fázisTaking peopleA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Calgary, Edmonton, Montreal, Ottawa
- Életkor
- Up to 25 év
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00 - No phaseTaking peopleTargeted Pediatric High-Grade Glioma Therapy
- Where
- Montreal, Toronto
- Életkor
- 12 hónap to 39 év
- People
- 350 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05839379 - 2. fázisTaking peopleStudy of Olutasidenib and Temozolomide in HGG
- Where
- Montreal, Toronto
- Életkor
- 12 év to 39 év
- People
- 60 worldwide
- Run by
- Rigel Pharmaceuticals
See details and how to joinNCT06161974 - No phaseTaking peopleThe Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
- Where
- London, Ottawa
- Életkor
- 18 év and over
- People
- 50
- Run by
- Ottawa Hospital Research Institute
See details and how to joinNCT06850766 - Korai 1. fázisTaking peopleLorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Where
- Montreal, Toronto
- Életkor
- 1 év to 21 év
- People
- 15 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT06333899 - No phaseCsak meghívásosThe Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors
- Where
- Halifax
- Életkor
- 18 év and over
- People
- 24
- Run by
- Nova Scotia Health Authority
See details and how to joinNCT05116137 - 2. fázisTaking peopleStudy of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Where
- Montreal, Toronto
- Életkor
- 12 hónap to 39 év
- People
- 120 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05843253 - 2. fázisTaking peopleDaily Temozolomide for Elderly Patients With Unmethylated MGMT- Promoter Newly Diagnosed GliOblatoma
- Where
- Toronto
- Életkor
- 65 év and over
- People
- 118
- Run by
- Sunnybrook Health Sciences Centre
See details and how to joinNCT07476794 - 1/2. fázisTaking peopleA Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- LigaChem Biosciences, Inc.
See details and how to joinNCT05941507 - 1. fázisTaking peopleFocused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy
- Where
- Toronto
- Életkor
- 18 év to 85 év
- People
- 10
- Run by
- Sunnybrook Health Sciences Centre
See details and how to joinNCT07179328 - 1/2. fázisTaking peopleIA Carboplatin + Radiotherapy in Relapsing GBM
- Where
- Sherbrooke
- Életkor
- 18 év and over
- People
- 35
- Run by
- Université de Sherbrooke
See details and how to joinNCT03672721 - 2. fázisTaking peopleIntraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma
- Where
- Sherbrooke
- Életkor
- 18 év and over
- People
- 120
- Run by
- Université de Sherbrooke
See details and how to joinNCT06356883 - 2. fázisTaking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Edmonton, Montreal, Toronto, Winnipeg
- Életkor
- 18 év and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - No phaseTaking peopleTHERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM)
- Where
- Ottawa
- Életkor
- 18 év and over
- People
- 20
- Run by
- Ottawa Hospital Research Institute
See details and how to joinNCT05326334